Are other computer science sectors stealing BioTech's thunder? In recent years, BioTech startups are experiencing historic levels of demand, yet funds for the biotech sector are shrinking, while the industry is growing.
According to this report, "other areas" of technology are seeing greater interest from venture capital firms. I wonder what this could mean. Aside from the obvious categories like e-commerce, software, and so forth; perhaps areas of STEM they are shifting focus to are artificial intelligence, augmented reality, and virtual reality? We certainly hope so, science is too meaningful to pass up on.
One would think in light of the solid performance in biotech that we’d either be growing within the venture sector, or at least holding our own as a share of the industry. As I wrote in August, that’s surprisingly not the case: biotech has been shrinking as a share of the asset class over the past few years, moving from 19% of investments in 2010 down to 12-13% in 2015-2016. That’s over a one-third reduction in “market share” for biotech despite its stellar performance.